Bexagliflozin tablets, placebo

DRUG2 trials

Sponsors

Theracos

Conditions

Diabetes Mellitus, Type 2Type2 Diabetes Mellitus

Phase 2

A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus

CompletedNCT02390050

TheracosDiabetes Mellitus, Type 2

Start: 2015-05-12End: 2016-06-03Updated: 2021-06-29

Phase 3

Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

CompletedNCT03259789

TheracosType2 Diabetes Mellitus

Start: 2017-11-28End: 2019-01-23Updated: 2021-07-07

Related Papers

1117-P: Cardiovascular and Glycemic Benefits of Bexagliflozin as an Adjunct to Metformin for the Treatment of Type 2 Diabetes in Adults: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Diabetes2020-06-013 citations